GTHP (Guided Therapeutics) OCF Margin %: 0.00% (As of Mar. 2026)


GTHP Guided Therapeutics Inc GTHP
18 GF Score
Price $0.24
! 4 Warning Signs
View Full Analysis

What is Guided Therapeutics OCF Margin %?

Guided Therapeutics GTHP -7.69% 18 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates GTHP with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Guided Therapeutics ranks worse than 87.36% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Guided Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-0.62 Mil. Guided Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Guided Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Guided Therapeutics's current OCF Yield % is -5.84%.

The historical rank and industry rank for Guided Therapeutics's OCF Margin % or its related term are showing as below:

GTHP' s OCF Margin % Range Over the Past 10 Years
Min: -15985.71   Med: -1901.84   Max: -139.24
Current: -176.53

During the past 13 years, the highest OCF Margin % of Guided Therapeutics was -139.24%. The lowest was -15985.71%. And the median was -1901.84%.

GTHP's OCF Margin % is ranked worse than
87.36% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs GTHP: -176.53

Guided Therapeutics OCF Margin % Related Terms

Guided Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Guided Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guided Therapeutics OCF Margin % Chart

Guided Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,965.43 -11,376.92 -1,781.63 -15,985.71 -139.24

Guided Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -144.44 -461.67 -49.32 0.00

GTHP vs LFWD, VNRX, IRIX: OCF Margin % Comparison

For the Medical Devices subindustry, Guided Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guided Therapeutics OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guided Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Guided Therapeutics's OCF Margin % falls into.


GTHP
18GF Score
Guided Therapeutics Inc GTHP
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guided Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Guided Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.068/0.767
=-139.24 %

Guided Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.617/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Guided Therapeutics (GTHP) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Guided Therapeutics and its competitors. According to the industry distribution chart, Guided Therapeutics ranks #712 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 87.4%.
Is Guided Therapeutics' OCF Margin % too high?
Guided Therapeutics' current OCF Margin % is 0.00%. Based on the distribution chart, Guided Therapeutics ranks #712 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Guided Therapeutics has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Guided Therapeutics' OCF Margin % compare to LFWD and VNRX?
According to the Medical Devices & Instruments industry distribution chart, Guided Therapeutics ranks #712 out of 815 companies for OCF Margin %. This places Guided Therapeutics in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Guided Therapeutics and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guided Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guided Therapeutics stock overvalued right now?
Guided Therapeutics (GTHP) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Guided Therapeutics' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Guided Therapeutics (GTHP), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guided Therapeutics Business Description

Address 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA, USA, 30092
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and the extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
18GF Score

Get the complete analysis for GTHP

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.24
Price